These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6976)

  • 21. Preliminary evidence that syrosingopine produces a selective depletion of central stores of sympathomimetic amines.
    Turner TA; Spencer PS
    J Pharm Pharmacol; 1971 Dec; 23(12):977-8. PubMed ID: 4402031
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of morphine on the turnover of brain catecholamines and serotonin in rats-chronic morphine administration.
    Theiss P; Papeschi R; Herz A
    Eur J Pharmacol; 1975 Dec; 34(2):263-71. PubMed ID: 791659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphine and ethanol: selective depletion of regional brain calcium.
    Ross DH; Medina MA; Cardenas HL
    Science; 1974 Oct; 186(4158):63-5. PubMed ID: 4420821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
    Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamines and the mechanisms of action of antitussive drugs in rats.
    Kamei J; Ogawa M; Kasuya Y
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):117-27. PubMed ID: 2965557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of catecholamine turnover rate in brain regions of rats exposed prenatally to morphine.
    Vathy I; Rimanoczy A; Eaton RC; Katay L
    Brain Res; 1994 Oct; 662(1-2):209-15. PubMed ID: 7859073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of reserpine, syrosingopine, and guanethidine on the retention of discriminated escape reversal: peripherally administered catecholamines cannot reverse the reserpine amnesia in this situation.
    Palfai T; Wichlinski L; Brown OM
    Behav Neural Biol; 1983 May; 38(1):120-6. PubMed ID: 6138025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of brain catecholamines in morphine analgesic action in morphine tolerant rats.
    Vedernikov YP
    J Pharm Pharmacol; 1970 Mar; 22(3):238-9. PubMed ID: 4399499
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence of the involvement of dopamine in the analgesic effect of nefopam.
    Esposito E; Romandini S; Merlo-Pich E; Mennini T; Samanin R
    Eur J Pharmacol; 1986 Sep; 128(3):157-64. PubMed ID: 3098570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ROLE OF SEVERAL SEROTONIN AND CATECHOLAMINE LIBERATORS IN THE PHENOMENON OF PAIN IN THE RAT].
    GASCON A
    Rev Can Biol; 1964 Jun; 23():169-86. PubMed ID: 14221453
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of methyl o-(4-hydroxy-3-methoxycinnamoyl) reserpate (CD-3400) on erection and ejaculation in dogs].
    Yonezawa A; Tadano T; Urano S; Kisara K; Kimura Y
    Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):239-49. PubMed ID: 6130031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinociceptive activity of morphine after injection of biogenic amines in the cerebral ventricles of the conscious rat.
    Sparkes CG; Spencer PS
    Br J Pharmacol; 1971 Jun; 42(2):230-41. PubMed ID: 5091158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic function in mouse head twitches induced by lithium and reserpine.
    Yamada K; Furukawa T
    Psychopharmacology (Berl); 1979 Mar; 61(3):255-60. PubMed ID: 109889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of drugs interfering with biogenic amines metabolism on gastric secretion and reserpine-ulcers development in rats.
    Hano J; Bugajski J; Wantuch C
    Pol J Pharmacol Pharm; 1978; 30(4):501-11. PubMed ID: 740552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of norepinephrine alpha 2-receptor activation for morphine-induced rat growth hormone secretion.
    Eriksson E; Edén S; Modigh K
    Neuroendocrinology; 1981 Aug; 33(2):91-6. PubMed ID: 6267499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indirect biochemical evidence that reserpine methiodide produces selective depletion of peripheral biogenic amines in rats.
    Sreemantula S; Boini KM; Koppula S; Kilari EK; Nammi S
    Pharmazie; 2005 Apr; 60(4):294-7. PubMed ID: 15881611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity.
    Lima L; Sourkes TL
    Neuroscience; 1986; 17(1):235-45. PubMed ID: 2938024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.